STAT3 and neoplasm: developed dual‐targeting nanocarriers for delivering the STAT3 silencing siRNA to both tumor cells and TAMs.[115] The gene expressions of STAT3 in tumor and TAMs cells were significantly down‐regulated, resulting in M2‐to‐M1 repolarization.